|
|||||
|
|
PCN11 The potential long-term comparative effectiveness of larotrectinib vs. lenvatinib or sorafenib for treatment of NTRK fusion-positive metastatic thyroid cancer |
|
| Authors: | J Carlson K Suh F Xia T Williamson S Sullivan |
| Institution: | 1. University of Washington, SEATTLE, WA, USA;2. University of Pittsburgh, Pittsburgh, PA, USA;3. Bayer U.S. LLC, Whippany, NJ, USA;4. Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Seattle, WA, USA |
| Abstract: | |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |